SI-BONE To Present at Canaccord Genuity 45th Annual Growth Conference on August 12, 2025
SI-BONE (Nasdaq: SIBN), a medical device company focused on sacropelvic disorders, has announced its participation in the Canaccord Genuity 45th Annual Growth Conference in Boston. The company's management will conduct a fireside chat on August 12, 2025, at 3:00 PM ET.
Investors can access the presentation through a webcast by registering online, and the live audio will be available on the company's website investor section. The webcast recording will remain accessible for replay for at least 90 days following the event.
SI-BONE (Nasdaq: SIBN), un'azienda di dispositivi medici specializzata in disturbi sacropelvici, ha annunciato la sua partecipazione alla 45陋 Conferenza Annuale sulla Crescita di Canaccord Genuity a Boston. Il management dell'azienda terr脿 una conversazione informale il 12 agosto 2025 alle 15:00 ET.
Gli investitori potranno seguire la presentazione tramite webcast registrandosi online; l'audio in diretta sar脿 disponibile nella sezione investitori del sito web dell'azienda. La registrazione del webcast rester脿 accessibile per la visione in differita per almeno 90 giorni dopo l'evento.
SI-BONE (Nasdaq: SIBN), una empresa de dispositivos m茅dicos enfocada en trastornos sacrop茅lvicos, ha anunciado su participaci贸n en la 45陋 Conferencia Anual de Crecimiento de Canaccord Genuity en Boston. La direcci贸n de la empresa realizar谩 una charla informal el 12 de agosto de 2025 a las 3:00 PM ET.
Los inversores podr谩n acceder a la presentaci贸n a trav茅s de una transmisi贸n en vivo registr谩ndose en l铆nea, y el audio en vivo estar谩 disponible en la secci贸n de inversores del sitio web de la empresa. La grabaci贸n de la transmisi贸n estar谩 disponible para reproducci贸n durante al menos 90 d铆as despu茅s del evento.
SI-BONE (雮橃姢雼�: SIBN)鞚� 觳滌灔瓿� 歆堩櫂鞐� 欷戩爯鞚� 霊� 鞚橂旮瓣赴 須岇偓搿�, 氤挫姢韯挫棎靹� 鞐措Μ電� Canaccord Genuity 鞝�45須� 鞐半 靹膘灔 旎嵓霟办姢鞐� 彀胳棳頃滊嫟瓿� 氚滍憸頄堨姷雼堧嫟. 須岇偓 瓴届榿歆勳潃 2025雲� 8鞗� 12鞚� 鞓ろ泟 3鞁�(霃欕秬鞁滉皠)鞐� 頇旍儊 雽�頇旊ゼ 歆勴枆頃� 鞓堨爼鞛呺媹雼�.
韴瀽鞛愲摛鞚� 鞓澕鞚� 霌彪鞚� 韱淀暣 鞗轨簮鞀ろ姼搿� 氚滍憸毳� 鞁滌箔頃� 靾� 鞛堨溂氅�, 鞁れ嫓臧� 鞓る敂鞓る姅 須岇偓 鞗轨偓鞚错姼 韴瀽鞛� 靹轨厴鞐愳劀 鞝滉车霅╇媹雼�. 鞗轨簮鞀ろ姼 雲鬼檾電� 頄夓偓 頉� 斓滌唽 90鞚缄皠 雼れ嫓氤搓赴搿� 鞚挫毄 臧�電ロ暕雼堧嫟.
SI-BONE (Nasdaq : SIBN), une entreprise de dispositifs m茅dicaux sp茅cialis茅e dans les troubles sacropelviens, a annonc茅 sa participation 脿 la 45e conf茅rence annuelle sur la croissance de Canaccord Genuity 脿 Boston. La direction de l'entreprise tiendra une discussion informelle le 12 ao没t 2025 脿 15h00 ET.
Les investisseurs pourront acc茅der 脿 la pr茅sentation via un webinaire en s'inscrivant en ligne, et l'audio en direct sera disponible dans la section investisseurs du site web de l'entreprise. L'enregistrement du webinaire restera accessible en replay pendant au moins 90 jours apr猫s l'茅v茅nement.
SI-BONE (Nasdaq: SIBN), ein Medizintechnikunternehmen mit Fokus auf sakropelvine Erkrankungen, hat seine Teilnahme an der 45. j盲hrlichen Wachstums-Konferenz von Canaccord Genuity in Boston angek眉ndigt. Das Management des Unternehmens wird am 12. August 2025 um 15:00 Uhr ET ein Gespr盲ch am Kamin f眉hren.
Investoren k枚nnen die Pr盲sentation 眉ber einen Webcast verfolgen, indem sie sich online registrieren. Der Live-Audio-Stream ist im Investor-Bereich der Unternehmenswebsite verf眉gbar. Die Aufzeichnung des Webcasts bleibt mindestens 90 Tage nach der Veranstaltung zum Nachh枚ren zug盲nglich.
- None.
- None.
SANTA CLARA, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming Canaccord Genuity 45th Annual Growth Conference in Boston, MA. Management will be hosting a fireside chat on Tuesday, August 12, 2025, at 12:00 p.m. Pacific Time/03:00 p.m. Eastern Time.
Investors interested in listening to the conference call may do so by registering at this link: . Live audio of the webcast will be available on the 鈥淚nvestors鈥� section of the company鈥檚 website at: . The webcast will be archived and available for replay for at least 90 days after the event.
About SI-BONE, Inc.
厂滨-叠翱狈贰听(狈础厂顿础蚕: SIBN)聽is a global leader in developing unique technologies for surgical treatment of sacropelvic disorders. Since pioneering minimally invasive SI joint surgery in 2009 with the iFuse Implant System庐,聽SI-BONE聽has supported over 4,600 physicians in performing a total of over 125,000 procedures. A unique body of clinical evidence supports the use of SI-BONE鈥檚 technologies with over 175 peer reviewed publications including four randomized controlled trials.聽SI-BONE聽has leveraged its leadership in minimally invasive SI joint fusion to commercialize novel solutions for adjacent markets, including adult deformity, spinopelvic and sacropelvic fixation and pelvic trauma.
For additional information on the company or the products, including risks and benefits, please visit .
SI-BONE, Sacropelvic Solutions, iFuse Implant System庐, iFuse Bedrock Granite, and iFuse TORQ, are registered trademarks, and iFuse 3D, iFuse TORQ TNT, and iFuse INTRA are trademarks of SI-BONE, Inc. 漏2025 SI-BONE, Inc. All Rights Reserved.聽
Investor Contact: Saqib Iqbal
FAQ
When is SI-BONE (SIBN) presenting at the Canaccord Genuity Growth Conference 2025?
How can investors access SI-BONE's (SIBN) Canaccord conference presentation?
How long will SI-BONE's (SIBN) Canaccord conference presentation be available for replay?
What does SI-BONE (SIBN) specialize in as a company?
